04.02.26 -- Generative AI Can Write The Code, But Who Builds In The Quality?

Handling multi-ton quantities of buffers, salts, and stabilizing chemicals in manufacturing can be difficult. See how dry granulation improves efficiency, safety, and process reliability.

Discover how AI converts traditional environmental monitoring into predictive intelligence that prevents contamination events before they occur, fundamentally changing cleanroom quality control.

Adopting AI and robotics enhance sterility and regulatory compliance and enable real-time decision-making and reduce human-borne contamination, ensuring the safe production of complex therapies.

Steven Facer and Laxxon Medical COO Klaus Kühne describe the capabilities of 3D screen printing for pharmaceutical production. Explore prototyping, IP protection, release profile possibilities, and more.

Medical device coatings are shifting from basic finishes to strategic tools that boost performance, safety, sustainability, and innovation through stronger partnerships and smarter materials.

Biopharma’s push for faster delivery is accelerating a shift from automated to autonomous manufacturing. Find out how self‑optimizing systems are shaping the next frontier.

Review advanced retrosynthetic analysis services and how these tools empower better, more efficient development of innovative small molecule drugs.

Outlined here are the inherent benefits of PFS and how they relate to the delivery of drugs, how SARS-CoV-2 could be fueling an explosive increase in PFS demand, and how a flexible CDMO is the key.

Examine how endotoxin assays use Factor C activation to generate measurable absorbance or fluorescence signals, with guidance on implementing scalable workflows.

Operational excellence in drug manufacturing comes from predictability. Standardized, consistent processes reduce volatility and ensure steady, high‑quality progress.

Product recalls are becoming a major concern in life sciences. Learn why your company must act now to strengthen quality systems and reduce risk across pharmaceuticals, devices, and biologics.

Targeted modalities are pushing the boundaries of technology and therapeutic effectiveness. Their potential to transform patient care depends on leveraging the right expertise and partnerships.

Move beyond raw data by using heat maps and site-specific limits to identify contamination hotspots. Transform your environmental monitoring into a proactive strategy for operational excellence.

Uncover a process that can be modified to fit your downstream process and serves as a complete solution for concentration and diafiltration.

Microscopic leaks in ophthalmic packaging can compromise sterility. Delve into how advanced vacuum decay testing delivers fast, reliable results, detecting defects as small as 5 microns.